H-Leu-Ser-Lys-Leu-OH_product_DataBase

CAS: 162559-45-7 F: C21H41N5O6 W: 459.58

H-Leu-Ser-Lys-Leu-OH (LSYL) is a latency-associated peptide at the amino terminus of LAP, with inhibitory effect on TGF-

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	H-Leu-Ser-Lys-Leu-OH (LSYL) is a latency-associated peptide at the amino terminus of LAP, with inhibitory effect on TGF-β1 activation. H-Leu-Ser-Lys-Leu-OH, binding with KRFK (HY-P3970), can block the signal transduction of TGF-β1, and prevent the progression of hepatic damage and fibrosis[1].
Invitro	H-Leu-Ser-Lys-Leu-OH (LSKL) 也可以阻断 TSP-1 对 TGF-β1 的激活，并降低 KRFK 肽对 TGF-β1 的激活[1]。
Name	H-Leu-Ser-Lys-Leu-OH
CAS	162559-45-7
Shortening	LSKL
Formula	C21H41N5O6
Molar Mass	459.58
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.

PeptideDB